305 related articles for article (PubMed ID: 23377182)
1. Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas.
Smith MJ; O'Sullivan J; Bhaskar SS; Hadfield KD; Poke G; Caird J; Sharif S; Eccles D; Fitzpatrick D; Rawluk D; du Plessis D; Newman WG; Evans DG
Nat Genet; 2013 Mar; 45(3):295-8. PubMed ID: 23377182
[TBL] [Abstract][Full Text] [Related]
2. Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas.
Smith MJ; Wallace AJ; Bennett C; Hasselblatt M; Elert-Dobkowska E; Evans LT; Hickey WF; van Hoff J; Bauer D; Lee A; Hevner RF; Beetz C; du Plessis D; Kilday JP; Newman WG; Evans DG
J Pathol; 2014 Dec; 234(4):436-40. PubMed ID: 25143307
[TBL] [Abstract][Full Text] [Related]
3. SMARCE1-related meningiomas: A clear example of cancer predisposing syndrome.
Fiorentini E; Giunti L; Di Rita A; Peraio S; Fonte C; Caporalini C; Buccoliero AM; Censullo ML; Gori G; Noris A; Pasquariello R; Battini R; Pavone R; Giordano F; Giglio S; Rinaldi B
Eur J Med Genet; 2023 Jul; 66(7):104784. PubMed ID: 37164167
[TBL] [Abstract][Full Text] [Related]
4. SMARCE1 mutations in pediatric clear cell meningioma: case report.
Evans LT; Van Hoff J; Hickey WF; Smith MJ; Evans DG; Newman WG; Bauer DF
J Neurosurg Pediatr; 2015 Sep; 16(3):296-300. PubMed ID: 26114992
[TBL] [Abstract][Full Text] [Related]
5. SMARCE1 mutation screening in classification of clear cell meningiomas.
Smith MJ; Ahn S; Lee JI; Bulman M; Plessis DD; Suh YL
Histopathology; 2017 Apr; 70(5):814-820. PubMed ID: 27891692
[TBL] [Abstract][Full Text] [Related]
6. Germline and somatic mutations in meningiomas.
Smith MJ
Cancer Genet; 2015 Apr; 208(4):107-14. PubMed ID: 25857641
[TBL] [Abstract][Full Text] [Related]
7. Pediatric clear cell meningioma involving the middle cranial fossa in the context of NF2 and SMARCE1 mutations.
Libert DM; Prayson RA
Ann Diagn Pathol; 2020 Jun; 46():151516. PubMed ID: 32311644
[TBL] [Abstract][Full Text] [Related]
8. Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis.
Tauziede-Espariat A; Parfait B; Besnard A; Lacombe J; Pallud J; Tazi S; Puget S; Lot G; Terris B; Cohen J; Vidaud M; Figarella-Branger D; Monnien F; Polivka M; Adle-Biassette H; Varlet P
Brain Pathol; 2018 Jul; 28(4):466-474. PubMed ID: 28474749
[TBL] [Abstract][Full Text] [Related]
9. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.
De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L
Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144
[TBL] [Abstract][Full Text] [Related]
10. Clear cell meningiomas are defined by a highly distinct DNA methylation profile and mutations in SMARCE1.
Sievers P; Sill M; Blume C; Tauziede-Espariat A; Schrimpf D; Stichel D; Reuss DE; Dogan H; Hartmann C; Mawrin C; Hasselblatt M; Stummer W; Schick U; Hench J; Frank S; Ketter R; Schweizer L; Schittenhelm J; Puget S; Brandner S; Jaunmuktane Z; Küsters B; Abdullaev Z; Pekmezci M; Snuderl M; Ratliff M; Herold-Mende C; Unterberg A; Aldape K; Ellison DW; Wesseling P; Reifenberger G; Wick W; Perry A; Varlet P; Pfister SM; Jones DTW; von Deimling A; Sahm F;
Acta Neuropathol; 2021 Feb; 141(2):281-290. PubMed ID: 33319313
[TBL] [Abstract][Full Text] [Related]
11. The importance of genetic counseling and screening for people with pathogenic SMARCE1 variants: A family study.
Shoakazemi A; Hewitt A; Smith MJ; du Plessis D; Thomas O; Stivaros SM; Deniz K; Hammerbeck-Ward C; Rutherford SA; King AT; Evans DG
Am J Med Genet A; 2021 Feb; 185(2):561-565. PubMed ID: 33185983
[TBL] [Abstract][Full Text] [Related]
12. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
13. SMARCB1 mutations are not a common cause of multiple meningiomas.
Hadfield KD; Smith MJ; Trump D; Newman WG; Evans DG
J Med Genet; 2010 Aug; 47(8):567-8. PubMed ID: 20472658
[TBL] [Abstract][Full Text] [Related]
14. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.
van den Munckhof P; Christiaans I; Kenter SB; Baas F; Hulsebos TJ
Neurogenetics; 2012 Feb; 13(1):1-7. PubMed ID: 22038540
[TBL] [Abstract][Full Text] [Related]
15. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
[TBL] [Abstract][Full Text] [Related]
16. Pediatric intracranial clear cell meningioma associated with a germline mutation of SMARCE1: a novel case.
Raffalli-Ebezant H; Rutherford SA; Stivaros S; Kelsey A; Smith M; Evans DG; Kilday JP
Childs Nerv Syst; 2015 Mar; 31(3):441-7. PubMed ID: 25249420
[TBL] [Abstract][Full Text] [Related]
17. Molecular alterations in the neurofibromatosis type 2 gene and its protein rarely occurring in meningothelial meningiomas.
Evans JJ; Jeun SS; Lee JH; Harwalkar JA; Shoshan Y; Cowell JK; Golubic M
J Neurosurg; 2001 Jan; 94(1):111-7. PubMed ID: 11147878
[TBL] [Abstract][Full Text] [Related]
18. SWI/SNF chromatin remodeling complex alterations in meningioma.
Gill CM; Loewenstern J; Rutland JW; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Fowkes M; Shrivastava RK
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3431-3440. PubMed ID: 33715086
[TBL] [Abstract][Full Text] [Related]
19. Loss of chromosome 22 and absence of NF2 gene mutation in a case of multiple meningiomas.
Lomas J; Bello MJ; Alonso ME; Gonzalez-Gomez P; Arjona D; Kusak ME; de Campos JM; Sarasa JL; Rey JA
Hum Pathol; 2002 Mar; 33(3):375-8. PubMed ID: 11979381
[TBL] [Abstract][Full Text] [Related]
20. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]